|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,244.00 JPY | +0.22% |
|
+1.76% | +0.37% |
| 01-12 | Ionis Pharmaceuticals, Inc. Provides Additional Updates on Key Milestones Expected in 2026 | CI |
| 11-25 | US FDA approves Otsuka's drug for a type of kidney disease | RE |
Analyst Reco.
Search
No results for this search
- Stock Market
- Equities
- 4768 Stock
- News Otsuka Corporation
- Analyst Reco.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















